M B Chancellor Selected Research

M B Chancellor Research Topics

Disease

7	Stress Urinary Incontinence 03/2009 - 02/2000
5	Pain (Aches) 01/2015 - 03/2001
5	Erectile Dysfunction 01/2009 - 01/2001
5	Urinary Retention 01/2002 - 05/2000
4	Spinal Cord Injuries (Spinal Cord Injury) 05/2009 - 08/2000
4	Overactive Urinary Bladder (Overactive Bladder) 04/2008 - 02/2000
3	Ataxia (Dyssynergia) 04/2001 - 03/2000
2	Pelvic Pain 04/2009 - 08/2000
2	Urethral Obstruction 01/2002 - 01/2002
2	Interstitial Cystitis (Interstitial Cystitis, Chronic) 06/2001 - 03/2001
2	Neurogenic Urinary Bladder (Bladder, Neurogenic) 05/2001 - 03/2001
2	Abnormal Reflex (Hyperreflexia) 11/2000 - 08/2000
2	Urge Urinary Incontinence (Urge Incontinence) 11/2000 - 08/2000
1	Colitis 01/2015
1	Urinary Bladder Diseases (Bladder Diseases) 10/2014
1	Constipation 04/2009
1	Prostatic Diseases 12/2006
1	Visceral Pain 11/2001
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 07/2001
1	Urinary Incontinence 05/2001
1	Infections 05/2001
1	Prostatitis 03/2001
1	Spinal Cord Diseases 11/2000
1	Osteomyelitis 08/2000
1	Obesity 08/2000
1	Wound Infection (Wound Infections) 08/2000
1	Neoplasm Metastasis (Metastasis) 08/2000
1	Pathologic Constriction (Stenosis) 07/2000
1	Urinary Tract Infections (Urinary Tract Infection) 07/2000
1	Autonomic Dysreflexia 07/2000
1	Prostatic Neoplasms (Prostate Cancer) 05/2000
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 05/2000
1	Dysuria 05/2000
1	Referred Pain 05/2000
1	Hemorrhage 03/2000
1	Acute Pain 02/2000

Drug/Important Bio-Agent (IBA)

3	Type A Botulinum Toxins (Botox)FDA Link 12/2006 - 01/2002
3	Nitric Oxide Synthase (NO Synthase)IBA 05/2003 - 01/2001
3	SuspensionsIBA 01/2002 - 03/2001
3	Botulinum Toxins (Botulinum Toxin)IBA 01/2002 - 04/2001
3	Cholinergic Antagonists (Anticholinergics)IBA 05/2001 - 02/2000
2	resiniferatoxinIBA 01/2015 - 02/2000
2	Capsaicin (Zostrix)FDA Link 01/2015 - 02/2000
2	EnzymesIBA 05/2009 - 05/2001
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2009 - 09/2007
2	Tetrodotoxin (Tetradotoxin)IBA 11/2001 - 06/2001
1	Messenger RNA (mRNA)IBA 01/2015
1	AcidsIBA 01/2015
1	Dihydrotachysterol (AT 10)IBA 01/2015
1	Acrolein (Aqualin)IBA 10/2014
1	gamma-Aminobutyric Acid (GABA)IBA 05/2009
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 05/2009
1	Proteins (Proteins, Gene)FDA Link 04/2009
1	Opiate AlkaloidsIBA 04/2009
1	Analgesics (Analgesic Drugs)IBA 04/2009
1	Narcotics (Narcotic Analgesics)IBA 04/2009
1	Nerve Growth Factors (Neurotrophins)IBA 03/2009
1	NeurturinIBA 01/2009
1	darifenacin FDA Link 04/2008
1	incobotulinumtoxinA FDA Link 03/2006
1	Sodium Channels (Sodium Channel)IBA 11/2001
1	NAV1.8 Voltage-Gated Sodium ChannelIBA 06/2001
1	Potassium Chloride FDA LinkGeneric 06/2001
1	Protamines (Protamine Sulfate)FDA Link 06/2001
1	preproenkephalinIBA 06/2001
1	oxybutynin (Tavor)FDA LinkGeneric 05/2001
1	ImmunosorbentsIBA 05/2001
1	Nerve Growth Factor (NGF)IBA 05/2001
1	Tolterodine Tartrate (Detrol)FDA Link 05/2001
1	Anticonvulsants (Antiepileptic Drugs)IBA 03/2001
1	Gabapentin (Neurontin)FDA LinkGeneric 03/2001
1	Therapeutic UsesIBA 03/2001
1	Tachykinin Receptors (Tachykinin Receptor)IBA 01/2001
1	CollagenIBA 01/2001
1	Biological ProductsIBA 12/2000
1	Parasympatholytics (Antispasmodics)IBA 11/2000
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2000

Therapy/Procedure

7	Therapeutics 10/2014 - 02/2000
3	Injections 03/2009 - 03/2006
3	Stents 03/2001 - 05/2000
2	Drug Therapy (Chemotherapy) 05/2003 - 08/2000
1	Neurological Rehabilitation 03/2001
1	Denervation 08/2000
1	Conservative Treatment 08/2000
1	Suture Anchors 08/2000
1	Aftercare (After-Treatment) 05/2000
1	Transurethral Resection of Prostate (TURP) 05/2000
1	Brachytherapy 05/2000
1	Prostheses and Implants (Prosthesis) 03/2000
1	Intravesical Administration 02/2000